Loading company…
Mystbio provides molecular diagnostic tools and medical data solutions, including products for oncology.
Mystbio provides molecular diagnostic and medical data solutions for healthcare providers and clinical institutions. Its oncology offerings include the OncoMUSE platform and algorithms for irAEs assessment, aging, and precision nutrition. Founded in 2024, the company is based in Beijing, China. It sells diagnostic reagents to hospitals, cancer centers, and clinical laboratories.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in